Who uses the care planning code? Memory-care expert says the answer matters
A memory-care expert is the latest advocate for greater use and expansion of Medicare’s largely untapped dementia care planning benefit.
Alzheimer’s
Blood pressure control, not drug type, key to lowering dementia risk
Dementia risk is lower when hypertension is well controlled, no matter the class of blood pressure drug used, according to a recent study.
Dementia care planning benefit largely untapped: testimony
Clinicians are the key to spreading awareness of a little-used Medicare benefit that supports long-term quality of life, advocates told Congress.
Seniors with Alzheimer’s who take antipsychotics hospitalized more frequently
Seniors with Alzheimer’s disease who are prescribed antipsychotics spend 53% more days hospitalized than those not taking antipsychotics.
Clinical Briefs for Wednesday, Nov. 6
Single odds-defying case may lead to new Alzheimer’s treatments … Fully digital Alzheimer’s study to track risk factors in 400,000 volunteers … Blood samples may identify those at risk for frailty … FDA approves Talicia® for treatment of H. pylori in adults
Dementia unlikely for those who get past these hurdles, study finds
A brief cognitive screening combined with an olfactory test may rule out future dementia in people with mild cognitive impairment, say researchers.
Clinical Briefs for Tuesday, October 29
New antiviral drug effectively treats influenza infection … Biogen’s drug news could ‘open the floodgates’ for Alzheimer’s drugs: STAT … Oscillating vest keeps COPD sufferers out of hospital … Thiazolidinedione use in diabetes linked to lower Parkinson’s risk
Clinical Briefs for Friday, October 25
Vitamin D deficiency linked to poor muscle function in seniors … Immune response to influenza is culprit in poor flu outcomes … ‘Whole concept of senior living will change’ if Alzheimer’s drug is approved … Antidepressants show little clinical benefit for major depressive disorders
Clinical Briefs for Wednesday, October 23
Surprise move: Biogen presses ahead on failed Alzheimer’s drug … Robot ‘colleague’ in pilot test for dementia patients at two nursing homes … Breaking thought patterns raises chance of depression recovery … FDA, FTC warn company that claims to treat Parkinson’s, Alzheimer’s with cannabinoids
Clinical Briefs for Wednesday, October 9
Nuplazid slows relapses in dementia-related psychosis … Dog ownership may extend life of heart attack, stroke survivors … Growth factor shows promise for treating knee osteoarthritis … Drugs for arthritis, psoriasis may reduce Alzheimer’s risk
Next post in Clinical Daily News
